Search results
However, as salvarsan became more widely used, side effects became more frequently reported, and Ehrlich suffered a period of humiliating accusations.
- www.nature.com
We would like to show you a description here but the site...
- Paul Ehrlich's magic bullet concept: 100 years of progress
One hundred years ago, Paul Ehrlich, the founder of...
- www.nature.com
Feb 5, 2016 · The seminal contributions of Paul Ehrlich and his colleagues also led to the birth and foundation of modern chemistry, hematology, immunology, chemotherapy, pharmacology and oncology. Finally, the concept of specific drug development and global standardization of diagnostic and therapeutic approaches are based on the seminal work of Paul ...
- Peter Valent, Bernd Groner, Udo Schumacher, Giulio Superti-Furga, Meinrad Busslinger, Robert Kralovi...
- 10.1159/000443526
- 2016
- J Innate Immun. 2016 Mar; 8(2): 111-120.
Paul Ehrlich ( German: [ˈpaʊl ˈʔeːɐ̯lɪç] ⓘ; 14 March 1854 – 20 August 1915) was a Nobel Prize -winning German physician and scientist who worked in the fields of hematology, immunology, and antimicrobial chemotherapy. Among his foremost achievements were finding a cure for syphilis in 1909 and inventing the precursor technique to ...
Aug 5, 2008 · Key Words: Paul Ehrlich, Arsenicals, Arsphenamine, Dyes, Animal experimentation, Therapeutic pharmacology, Chemotherapy, Syphilis, Side-chain theory Introduction Paul Ehrlich (1854–1915) (fig. (fig.1) 1 ) and the Russian immunologist Ilya Mechnikov (1845–1916), who discovered phagocytosis, received the Nobel Prize for Physiology or Medicine ...
- Fèlix Bosch, Laia Rosich
- 10.1159/000149583
- 2008
- Pharmacology. 2008 Oct; 82(3): 171-179.
Sep 1, 2004 · Paul Ehrlich, a founding father in fields across a wide range of medical sciences, was born 150 years ago. ... Many so-called side effects of Salvarsan turned out to be due to improper handling of ...
Jan 10, 2014 · More recently, understanding that maintenance of high trough levels contributed to these adverse effects, the implementation of once-daily dosing achieved excellent activity (on the basis of the bactericidal C max mode of action), whereas lower trough levels reduced side effects.
People also ask
What did Paul Ehrlich say about chemotherapeutics?
How did Ehrlich's chemotherapy lead to antibacterial chemotherapy?
Why did Ehrlich develop chemotherapeutic index?
